Background: Engaging families in care leads to improved patient- and family-centreed outcomes and is recommended by cardiovascular societies. However, no validated tools are currently available to measure family engagement in acute cardiac care. We previously described the development of the FAMily Engagement (FAME) instrument. The purpose of this study is to validate the FAME instrument in acute cardiac care.
Methods: The FAME questionnaire was administered to family members of patients in a cardiovascular intensive care unit and ward at an academic tertiary care hospital in Montreal, Canada. After hospital discharge, we assessed family satisfaction in the intensive care unit (FS-ICU) and mental health (using the Hospital Anxiety and Depression Scale [HADS]). Higher FAME scores indicate increased care engagement. Reliability was assessed using internal consistency testing. Predictive validity was evaluated by assessing the relationship between the FAME score and the FS-ICU score and whether the FAME score was correlated with the HADS score. Convergent validity was assessed by comparing the FAME score with engagement elements of the FS-ICU score.
Results: A total of 160 family participants were included (age 54.8 ± 14.8 years; 66% women; 36% non-White). The most common relationships to the patient were spouse/partner and adult child (both n = 62; 39%). The mean FAME score was 70.8 ± 16.0. The FAME instrument had high internal consistency (Cronbach's = 0.86). The FAME score was associated with family satisfaction in the multivariable analysis ( < 0.001). No correlation occurred between FAME and HADS anxiety or depression scores.
Conclusions: The FAME tool demonstrated reliability and convergent and predictive validity in the acute care cardiac population. Further research is needed to explore whether selected engagement interventions can impact the FAME score favourably.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066429 | PMC |
http://dx.doi.org/10.1016/j.cjco.2022.11.021 | DOI Listing |
Epilepsia Open
November 2024
Department of Neuroscience, Reproductive Sciences and Odontostomatology, Federico II University of Naples, Naples, Italy.
Familial adult myoclonus epilepsy (FAME) management relies on antiseizure medications (ASMs), which inadequately address myoclonus and cortical tremor. This study evaluates Perampanel (PER), an AMPA-receptor antagonist, for treating FAME symptoms. Fifteen FAME2 patients participated in an observational prospective study.
View Article and Find Full Text PDFJACC Adv
September 2024
Department of Medicine, Emory School of Medicine, Atlanta, Georgia, USA.
Int J Cardiol
January 2025
Center for Imaging, EPFL, Lausanne, Switzerland.
Background: Quantitative coronary angiography (QCA) typically employs traditional edge detection algorithms that often require manual correction. This has important implications for the accuracy of downstream 3D coronary reconstructions and computed haemodynamic indices (e.g.
View Article and Find Full Text PDFSci Total Environ
November 2024
KWR Water Research Institute, P.O. Box 1072, 3430 BB Nieuwegein, the Netherlands; Department of Freshwater and Marine Ecology (FAME), Institute for Biodiversity and Ecosystem Dynamics (IBED), University of Amsterdam (UvA), Science Park 904, Amsterdam 1098XH, the Netherlands.
Drug consumption estimates are traditionally based on surveys or information from police seizures. Alternatively, residues of illicit drugs in untreated wastewater (influent) can be used to calculate mass loads and subsequently estimate drug consumption in the community throughout the week. For this purpose, wastewater is commonly sampled for seven consecutive days within the Sewage analysis CORe group Europe (SCORE), while other sampling schemes may be implemented in long-term studies outside this consortium.
View Article and Find Full Text PDFActa Neurol Belg
December 2024
Pediatric Physical Medicine and Rehabilitation Unit, IRCCS Institute of Neurological Sciences of Bologna, Via Altura 3, Bologna, Italy, IRCCS Institute of Neurological Sciences of Bologna, Via Altura 3, Bologna, Italy.
Background: Effective rehabilitation of peripheral facial paralysis (PFP) requires reliable assessment tools. This systematic review aimed to identify and validate instruments used in PFP rehabilitation, categorizing them according to the ICF framework.
Methods: A comprehensive search was conducted across PubMed, Cinahl, Web of Science, and Scopus up to April 2024.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!